Tower Research Capital LLC (Trc) Reviva Pharmaceuticals Holdings, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.53 Billion
- Q2 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,424 shares of RVPH stock, worth $526. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,424
Previous 8,247
82.73%
Holding current value
$526
Previous $7,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding RVPH
# of Institutions
55Shares Held
14.5MCall Options Held
4.9MPut Options Held
29.7K-
Diadema Partners LP Morristown, NJ2.74MShares$1.01 Million0.32% of portfolio
-
Armistice Capital, LLC New York, NY2.69MShares$996,0400.02% of portfolio
-
Heights Capital Management, Inc San Francisco, CA1.83MShares$677,0640.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.8MShares$667,5140.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.49MShares$550,5750.0% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $7.56M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...